Micron Announces Early Tender Results
Apr 10, 2017 12:05 pm UTC| Business
BOISE, Idaho, April 10, 2017 -- Micron Technology, Inc. (Nasdaq:MU), (the "Company" or "Micron") today announced the early tender results for its previously announced tender offers (the "Tender Offers") to purchase the...
Gentex Recognized by General Motors as a 2016 Supplier of the Year Winner
Apr 10, 2017 12:05 pm UTC| Business
ZEELAND, Mich., April 10, 2017 -- Gentex Corporation (NASDAQ:GNTX) was named a GM Supplier of the Year by General Motors during its 25th annual Supplier of the Yearawards ceremony held Friday, March 31 in Orlando,...
Gentex Recognized by General Motors as a 2016 Supplier of the Year Winner
Apr 10, 2017 12:05 pm UTC| Business
ZEELAND, Mich., April 10, 2017 -- Gentex Corporation (NASDAQ:GNTX) was named a GM Supplier of the Year by General Motors during its 25th annual Supplier of the Yearawards ceremony held Friday, March 31 in Orlando,...
Gentex Recognized by General Motors as a 2016 Supplier of the Year Winner
Apr 10, 2017 12:04 pm UTC| Business
ZEELAND, Mich., April 10, 2017 -- Gentex Corporation (NASDAQ:GNTX) was named a GM Supplier of the Year by General Motors during its 25th annual Supplier of the Yearawards ceremony held Friday, March 31 in Orlando,...
Gentex Recognized by General Motors as a 2016 Supplier of the Year Winner
Apr 10, 2017 12:04 pm UTC| Business
ZEELAND, Mich., April 10, 2017 -- Gentex Corporation (NASDAQ:GNTX) was named a GM Supplier of the Year by General Motors during its 25th annual Supplier of the Yearawards ceremony held Friday, March 31 in Orlando,...
Gentex Recognized by General Motors as a 2016 Supplier of the Year Winner
Apr 10, 2017 12:04 pm UTC| Business
ZEELAND, Mich., April 10, 2017 -- Gentex Corporation (NASDAQ:GNTX) was named a GM Supplier of the Year by General Motors during its 25th annual Supplier of the Yearawards ceremony held Friday, March 31 in Orlando,...
Apr 10, 2017 12:04 pm UTC| Business
HAYWARD, Calif., April 10, 2017 -- Anthera Pharmaceuticals. (Nasdaq:ANTH) today announced the completion of dosing in the randomized, double-blind, placebo controlled, Phase 2 BRIGHT-SC study of blisibimod in patients...